SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 9.25p
   
  • Change Today:
      0.000p
  • 52 Week High: 29.00p
  • 52 Week Low: 7.25p
  • Currency: UK Pounds
  • Shares Issued: 200.38m
  • Volume: 230,111
  • Market Cap: £18.54m

SBTX Overview

SkinBioTherapeutics is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix®, is based upon discoveries made by CSO Dr. Catherine O’Neill and Professor Andrew McBain at The University of Manchester.

1 Day Chart (24-04-2024)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -2271.3% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 140.4 n/a
Pr/Book 9.3  
Latest F'cast
Revenue 76.6% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

SBTX Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-19 n/a (1.36) (0.94)p n/a n/a n/a n/a 0.0%
30-Jun-20 n/a (1.62) (1.17)p n/a n/a n/a n/a 0.0%
30-Jun-21 n/a (1.50) (0.01)p n/a n/a n/a n/a 0.0%
30-Jun-22 0.07 (2.99) (1.78)p n/a n/a n/a n/a 0.0%
30-Jun-23 0.13 (3.01) (1.72)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

SBTX Company Announcements

Holding(s) in Company 11-Apr-2024 11:44 RNS
Conversion Notice & Total Voting Rights 05-Apr-2024 07:00 RNS
Half-year Report 22-Mar-2024 07:00 RNS

SBTX ShareCast News

SkinBioTherapeutics reports positive interim acn... 27-Feb-2024 ShareCast
SkinBioTherapeutics finalises acquisition of Der... 26-Jan-2024 ShareCast
SkinBioTherapeutics launches new consumer study ... 25-Oct-2023 ShareCast

Latest SBTX Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

SBTX Market Data

Currency UK Pounds
Share Price 9.25p
Change Today 0.000p
% Change 0.00 %
52 Week High 29.00p
52 Week Low 7.25p
Volume 230,111
Shares Issued 200.38m
Market Cap £18.54m

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
69% below the market average69% below the market average69% below the market average69% below the market average69% below the market average
77.36% below the sector average77.36% below the sector average77.36% below the sector average77.36% below the sector average77.36% below the sector average
Price Trend
81.65% below the market average81.65% below the market average81.65% below the market average81.65% below the market average81.65% below the market average
36.84% below the sector average36.84% below the sector average36.84% below the sector average36.84% below the sector average36.84% below the sector average
Income Not Available
Growth
18.01% above the market average18.01% above the market average18.01% above the market average18.01% above the market average18.01% above the market average
24.32% above the sector average24.32% above the sector average24.32% above the sector average24.32% above the sector average24.32% above the sector average

SBTX Dividends

No dividends found

Trades for 24-Apr-2024

Time Volume / Share Price
16:10 50,000 @ 9.10p
15:44 1,153 @ 9.00p
15:44 718 @ 9.00p
15:44 67 @ 9.00p
14:08 3,720 @ 9.17p

SBTX Key Personnel

CEO Stuart Ashman
CFO Manprit Singh Randhawa

Top of Page